Clinical Trials Directory

Trials / Completed

CompletedNCT05063266

Effects of Inspiratory Muscle Training in Pulmonary Hypertensive Patient

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Although the progressive nature of pulmonary hypertension (PH), including the impairment of respiratory muscle function, studies have demonstrated beneficial effects of physical exercise on the functional limitations caused by the disease in this population, being an important collaborator to the conventional drug therapy.Respiratory muscle training (RMT) improves functional capacity and quality of life (QoL) in patients.A randomized controlled trial was conducted to evaluate the effectiveness of this protocol on respiratory muscle strength and endurance, functional capacity. 18 subjects were allocated in 2 groups, group A was control group and group B was experimental group. Group A or Control group received deep breathing exercises. Group B received 30 minutes of IMT 6days weekly for 2 weeks by using a pressure threshold device. The purpose of this study was to investigate the effects of inspiratory muscle training (IMT) in PAH. To evaluate effectiveness of IMT mouth pressure device ,functional capacity using 6 minute walking test (6MWT)health assessment via SF 36 questionnaire were used before and after training protocol.

Conditions

Interventions

TypeNameDescription
OTHERDeep Breathing Exercisecontrol groups received deep breathing exercise 6 days a week for two weeks. Deep breathing exercises includes diaphragmatic breathing and pursed lip breathing.
OTHERInspiratory muscle TrainingTreatment group received inspiratory muscle training 20 minutes 6 days a week for two weeks.IMT was done by using pressure threshold device.

Timeline

Start date
2020-10-13
Primary completion
2021-07-02
Completion
2021-07-15
First posted
2021-10-01
Last updated
2021-10-01

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05063266. Inclusion in this directory is not an endorsement.